GS Development AB
Malmö, SE· latest recorded location
GS Development AB is named on 35 US grants and 15 published applications in this corpus. Its most frequent classification is F41G (Weapon sights).
- Granted patents
- 35
- Published applications
- 15
- Inventors
- 34
- Granted in 2026 so far
- 0
- Most recent grant
- 5 Apr 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 0 |
| 2003 | 3 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 5 | 1 |
| 2010 | 8 | 3 |
| 2011 | 3 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 4 | 0 |
| 2016 | 1 | 1 |
By publication year.
Technology areas
Share of 50 documents
- F41GWeapon sights18
- G02BOptical elements, systems or apparatus10
- A47LDomestic washing or cleaning6
- A61KMedicines and medical preparations6
- A61FFilters implantable into blood vessels4
- F41CSmallarms2
- H01MBatteries and fuel cells2
- Y02EClean energy generation and storage2
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2
- A61PTherapeutic uses of medicines1
Recent patents
Most cited
By later US patents
- Use of fatty acid esters as bioadhesive substances198US 5,955,502 A1999
- Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material167US 5,807,573 A1998
- Use of fatty acid esters as bioadhesive substances135US 6,228,383 B12001
- Controlled release composition forming a reversed micellar (L2) structure or a normal micellar (L1) structure88US 5,906,831 A1999
- Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones43US 6,503,523 B22003